K_\=`ijkK`d\@ek\ieXk`feXc Af`ek>DG8l[`k8ggifm\[ Recently, Zhejiang ChengYi Pharmaceutical Co., Ltd., which is located in the eastern coastal areas of China, received compliance FHUWL¿FDWHVDQGFRQ¿UPDWLRQ letter of GMP from Australian TGA, U.S. FDA and EU EMEA respectively, ZKLFKFRQ¿UPHGWKDWWKH company's main products, quality systems and plant facilities are comply with the regulatory requirements. In early September 2010, a team composed U.S. FDA, EU EMEA and Singapore HSA (observer status) and led by the Australian TGA had carried out a multi-national and multi-products GMP LQVSHFWLRQ7KH¿UVWWLPH international joint GMP audit has far-reaching meanings. According to the programme of the participating regulatory
authorities, the main objective is to see whether greater international collaboration can help to better distribute inspectional capacity, allowing more sites to be monitored with the opportunity to optimize resources and better assess inspectional needs. &KHQJ
